Psychiatry and Neurology, Neurology · Huntsville, AL
NPI
1255327557
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
185 Chateau Dr SW Ste 301
Huntsville, AL, 35801
Phone (256) 533-4402
Groups this clinician bills Medicare through
Medicare paid, 2024
$434K
35,257 services
Medicare patients, 2024
1,070
Average age 75
Drug cost, 2024
$4.5M
9,838 prescriptions
Company payments, 2025
$6,476
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott C Hitchcock was code J0585 (injection, onabotulinumtoxina, 1 unit), 26,100 times for 43 patients. In total Scott C Hitchcock billed 35,257 services in 36 codes, and Medicare paid $434K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 26,100 | 43 | $4.71 | $123K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 5,440 | 20 | $6.73 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 1,821 | 386 | $58.94 | $107K |
| 99214 Office E&M - Established | Office | 596 | 380 | $85.32 | $51K |
| 99213 Office E&M - Established | Office | 318 | 251 | $57.04 | $18K |
| 99222 Hospital E&M - Initial | Facility | 207 | 200 | $97.55 | $20K |
| 99239 Hospital Discharge Management | Facility | 163 | 159 | $85.88 | $14K |
| 64615 Musculoskeletal | Office | 87 | 26 | $103.04 | $8,964 |
| 99204 Office E&M - New | Office | 80 | 80 | $107.52 | $8,601 |
| 95874 Musculoskeletal | Office | 79 | 25 | $54.94 | $4,340 |
| 64616 Musculoskeletal | Office | 53 | 17 | $139.45 | $7,391 |
| 99231 Hospital E&M - Subsequent | Facility | 41 | 38 | $36.72 | $1,506 |
| 64612 Musculoskeletal | Office | 39 | 13 | $145.50 | $5,674 |
| 95886 Electrical Nerve Conductivity | Office | 34 | 34 | $64.87 | $2,206 |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $116.47 | $2,912 |
By year: 2022 $382K for 31,272 services; 2023 $407K for 34,009 services; 2024 $434K for 35,257 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott C Hitchcock prescribed most often to Medicare patients was Gabapentin, with 552 prescriptions and refills. In total Scott C Hitchcock wrote 9,838 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 552 | 913 | 130 | $13K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 453 | 453 | 73 | $9,923 |
| Donepezil Hcl Generic | 393 | 844 | 115 | $3,208 |
| Pregabalin Generic | 332 | 445 | 79 | $13K |
| Memantine Hcl Generic | 319 | 519 | 68 | $7,425 |
| Duloxetine Hcl Generic | 311 | 532 | 76 | $7,994 |
| Topiramate Generic | 271 | 485 | 58 | $3,279 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 264 | 470 | 53 | $6,739 |
| Clonazepam Generic | 260 | 261 | 37 | $1,401 |
| Trazodone Hcl Generic | 234 | 381 | 58 | $1,365 |
| Levetiracetam Generic | 219 | 490 | 52 | $7,882 |
| Rizatriptan Rizatriptan Benzoate | 207 | 226 | 52 | $3,228 |
| Sumatriptan Succinate Generic | 202 | 239 | 34 | $26K |
| Escitalopram Oxalate Generic | 197 | 343 | 49 | $1,516 |
| Buspirone Hcl Generic | 176 | 251 | 43 | $2,140 |
Brand drugs: 973 claims; generic drugs: 8,841 claims; opioid claims: 625.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott C Hitchcock $6,476 ($6,476 in general payments such as food, travel and fees) from 35 companies. The largest payer was Abbvie Inc. with $807.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 55 | $807 |
| UCB, Inc. UCB.BR | 47 | $668 |
| Pfizer Inc. PFE | 34 | $574 |
| CSL Behring CSL.AX | 14 | $392 |
| Biogen, Inc. BIIB | 17 | $326 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $315 |
| ACADIA Pharmaceuticals Inc ACAD | 12 | $246 |
| Neurocrine BioSciences, Inc. NBIX | 9 | $243 |
| Argenx US, Inc. ARGX | 7 | $210 |
| Alexion Pharmaceuticals, Inc. AZN | 9 | $200 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.